A
AbbVie Inc. (ABBV)
NYQ – Real vaqt narxi. Valyuta: USD
207.86
+5.08 (2.51%)
Yopilishda: May 12, 2026, 4:01 PM EDT
206.50
-1.46 (-0.70%)
Bozor oldidan: May 13, 2026, 7:03 AM EDT
Find any stock by ticker or company name

NYQ – Real vaqt narxi. Valyuta: USD
207.86
+5.08 (2.51%)
Yopilishda: May 12, 2026, 4:01 PM EDT
206.50
-1.46 (-0.70%)
Bozor oldidan: May 13, 2026, 7:03 AM EDT
This stock has a consensus price target of $238.87 based on the ratings of 32 analysts. The high is $294.00 and the low is $190.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 190 | $ 238.87 | $ 294 |
| O’zgarish | -6.30% | 17.80% | 44.98% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-05-04 | 13.68% | Evercore ISI Group | $232 → $236 | Maintains | Outperform |
| 2026-05-01 | 19.94% | Guggenheim | $249 → $249 | Reiterates | Buy |
| 2026-04-30 | 27.65% | Canaccord Genuity | $262 → $265 | Maintains | Buy |
| 2026-04-30 | 33.91% | Morgan Stanley | $270 → $278 | Maintains | Overweight |
| 2026-04-30 | 15.61% | Cantor Fitzgerald | $240 → $240 | Reiterates | Overweight |